1044 related articles for article (PubMed ID: 25476833)
1. Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury.
Yu D; Li M; Tian Y; Liu J; Shang J
Life Sci; 2015 Feb; 122():15-25. PubMed ID: 25476833
[TBL] [Abstract][Full Text] [Related]
2. Antioxidative effect of luteolin pretreatment on simulated ischemia/reperfusion injury in cardiomyocyte and perfused rat heart.
Zhang RQ; Li DY; Xu TD; Zhu SS; Pan HJ; Fang F; Wu X; Sun H
Chin J Integr Med; 2017 Jul; 23(7):518-527. PubMed ID: 26956461
[TBL] [Abstract][Full Text] [Related]
3. Effect of ulinastatin on myocardial ischemia-reperfusion injury through JNK and P38 MAPK signaling pathways.
Yang ZH; Lu YJ; Gu KP; Xiang ZY; Huang HM
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8658-8664. PubMed ID: 31646600
[TBL] [Abstract][Full Text] [Related]
4. Asiatic Acid Alleviates Myocardial Ischemia-Reperfusion Injury by Inhibiting the ROS-Mediated Mitochondria-Dependent Apoptosis Pathway.
Yi C; Song M; Sun L; Si L; Yu D; Li B; Lu P; Wang W; Wang X
Oxid Med Cell Longev; 2022; 2022():3267450. PubMed ID: 35198095
[TBL] [Abstract][Full Text] [Related]
5. Effect of propofol on myocardial ischemia-reperfusion injury through MAPK/ERK pathway.
Yan HJ; Qi GQ; Ma Y
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):11051-11061. PubMed ID: 31858577
[TBL] [Abstract][Full Text] [Related]
6. Luteolin Enhances Sarcoplasmic Reticulum Ca2+-ATPase Activity through p38 MAPK Signaling thus Improving Rat Cardiac Function after Ischemia/Reperfusion.
Zhu S; Xu T; Luo Y; Zhang Y; Xuan H; Ma Y; Pan D; Li D; Zhu H
Cell Physiol Biochem; 2017; 41(3):999-1010. PubMed ID: 28222421
[TBL] [Abstract][Full Text] [Related]
7. GAS5 promotes myocardial apoptosis in myocardial ischemia-reperfusion injury via upregulating LAS1 expression.
Liu SD; Meng WX; Xu L; Chi C; Sun X; Liu HY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8447-8453. PubMed ID: 30556886
[TBL] [Abstract][Full Text] [Related]
8. Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis.
Wang S; Li Y; Song X; Wang X; Zhao C; Chen A; Yang P
J Transl Med; 2015 Jul; 13():209. PubMed ID: 26136232
[TBL] [Abstract][Full Text] [Related]
9. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
[TBL] [Abstract][Full Text] [Related]
11. Prdx1 alleviates cardiomyocyte apoptosis through ROS-activated MAPK pathway during myocardial ischemia/reperfusion injury.
Guo W; Liu X; Li J; Shen Y; Zhou Z; Wang M; Xie Y; Feng X; Wang L; Wu X
Int J Biol Macromol; 2018 Jun; 112():608-615. PubMed ID: 29410271
[TBL] [Abstract][Full Text] [Related]
12. Midazolam suppresses ischemia/reperfusion-induced cardiomyocyte apoptosis by inhibiting the JNK/p38 MAPK signaling pathway.
Zhou W; Cai D
Can J Physiol Pharmacol; 2022 Feb; 100(2):117-124. PubMed ID: 34559975
[TBL] [Abstract][Full Text] [Related]
13. Antiapoptosis and mitochondrial effect of pioglitazone preconditioning in the ischemic/reperfused heart of rat.
Li J; Lang MJ; Mao XB; Tian L; Feng YB
Cardiovasc Drugs Ther; 2008 Aug; 22(4):283-91. PubMed ID: 18470603
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.
Chu Y; Teng J; Feng P; Liu H; Wang F; Wang H
Pharmacology; 2022; 107(1-2):14-27. PubMed ID: 34718238
[TBL] [Abstract][Full Text] [Related]
15. A novel pathway of NADPH oxidase/vascular peroxidase 1 in mediating oxidative injury following ischemia-reperfusion.
Zhang YS; He L; Liu B; Li NS; Luo XJ; Hu CP; Ma QL; Zhang GG; Li YJ; Peng J
Basic Res Cardiol; 2012 May; 107(3):266. PubMed ID: 22476986
[TBL] [Abstract][Full Text] [Related]
16. 7-O-Geranylquercetin induces apoptosis in gastric cancer cells via ROS-MAPK mediated mitochondrial signaling pathway activation.
Zhu Y; Jiang Y; Shi L; Du L; Xu X; Wang E; Sun Y; Guo X; Zou B; Wang H; Wang C; Sun L; Zhen Y
Biomed Pharmacother; 2017 Mar; 87():527-538. PubMed ID: 28076833
[TBL] [Abstract][Full Text] [Related]
17. Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells.
Chen J; Guo R; Yan H; Tian L; You Q; Li S; Huang R; Wu K
Basic Clin Pharmacol Toxicol; 2014 Apr; 114(4):293-304. PubMed ID: 24118820
[TBL] [Abstract][Full Text] [Related]
18. Aqueous extract of Cortex Dictamni protects H9c2 cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress and apoptosis by PI3K/Akt signaling pathway.
Li L; Zhou Y; Li Y; Wang L; Sun L; Zhou L; Arai H; Qi Y; Xu Y
Biomed Pharmacother; 2017 May; 89():233-244. PubMed ID: 28231545
[TBL] [Abstract][Full Text] [Related]
19. A novel synthetic analog of Militarin, MA-1 induces mitochondrial dependent apoptosis by ROS generation in human lung cancer cells.
Yoon DH; Lim MH; Lee YR; Sung GH; Lee TH; Jeon BH; Cho JY; Song WO; Park H; Choi S; Kim TW
Toxicol Appl Pharmacol; 2013 Dec; 273(3):659-71. PubMed ID: 24161344
[TBL] [Abstract][Full Text] [Related]
20. Luteolin protects HUVECs from TNF-α-induced oxidative stress and inflammation via its effects on the Nox4/ROS-NF-κB and MAPK pathways.
Xia F; Wang C; Jin Y; Liu Q; Meng Q; Liu K; Sun H
J Atheroscler Thromb; 2014; 21(8):768-83. PubMed ID: 24621786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
